SEC Form 4 · accession 0000899243-15-005117
Sorrento Therapeutics, Inc. · SRNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Uy
Officer — See Remarks
Period of report
Sep 18, 2015
Accepted (ET)
Sep 21, 2015 · 8:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850261
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 18, 2015 | S$0 | 47,500 | — | D | 201,735 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were sold at various prices between $12.90-$13.09
Remarks
Former Executive Vice President & Chief Commercial Officer